France HAS Approves AstraZeneca’s Evusheld for High-Risk Covid Cases
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Synopsis: Founded in 2018, Loop Health is a new age healthcare provider in India that combines high-quality primary care and insurance for…
Summary – Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its…
Summary – The agreement is an addition to the investments made by B Medical Systems in India following a bilateral summit between…
Summary – Lupin Diagnostics, a 100 percent subsidiary of Lupin Limited, has set up a state-of-the-art 45,000 sq. ft National Reference Laboratory…
Synopsis- Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the…
Synopsis – England’s National Institute for Health and Care Excellence (NICE) has given a thumbs up to Sobi’s paroxysmal nocturnal hemoglobinuria (PNH)…
Synopsis Dr Reddy’s Valsartan Tablets are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and…
Summary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Summary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…